Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-19 4:32 pm Purchase | 2025-02-16 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Nantahala Capital Management, LLC | 4,945,209 38.078% | 1,000,000 (+25.35%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | Fossil Group, Inc. FOSL | Nantahala Capital Management, LLC | 3,326,677 6.250% | 3,326,677 (New Position) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | IMAX Corporation IMAX | Nantahala Capital Management, LLC | 1,400,351 2.660% | 1,400,351 (New Position) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT | Nantahala Capital Management, LLC | 5,298,624 7.540% | 5,298,624 (New Position) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | The ONE Group Hospitality, Inc. STKS | Nantahala Capital Management, LLC | 2,087,394 6.770% | 403,321 (+23.95%) | Filing History |
| 2025-02-14 4:32 pm Sale | 2024-12-31 | 13G | Peloton Interactive, Inc. PTON | Nantahala Capital Management, LLC | 12,314,603 3.390% | -6,328,728 (-33.95%) | Filing History |
| 2025-02-14 4:32 pm Sale | 2024-12-31 | 13G | Rezolute, Inc. RZLT | Nantahala Capital Management, LLC | 2,857,982 4.932% | -2,108,735 (-42.46%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | Senti Biosciences, Inc. SNTI | Nantahala Capital Management, LLC | 509,283 9.990% | 509,283 (New Position) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | TELA Bio, Inc. TELA | Nantahala Capital Management, LLC | 3,974,326 9.990% | 2,059,200 (+107.52%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | Verastem, Inc. VSTM | Nantahala Capital Management, LLC | 4,523,184 9.990% | 470,980 (+11.62%) | Filing History |
| 2025-02-14 4:32 pm Sale | 2024-12-31 | 13G | Zevra Therapeutics, Inc. ZVRA | Nantahala Capital Management, LLC | 2,340,333 4.380% | -583,688 (-19.96%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | Altisource Portfolio Solutions S.A. ASPS | Nantahala Capital Management, LLC | 2,128,284 7.820% | 2,128,284 (New Position) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | OptiNose, Inc. OPTN | Nantahala Capital Management, LLC | 1,006,572 9.990% | 1,006,572 (New Position) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | InspireMD, Inc. NSPR | Nantahala Capital Management, LLC | 2,709,118 9.990% | 101,234 (+3.88%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | Surrozen, Inc. SRZN | Nantahala Capital Management, LLC | 338,930 9.990% | 3,899 (+1.16%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management, LLC | 4,349,435 9.990% | 398,148 (+10.08%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | Anebulo Pharmaceuticals, Inc. ANEB | Nantahala Capital Management, LLC | 3,547,398 8.630% | 3,547,398 (New Position) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | Apyx Medical Corporation APYX | Nantahala Capital Management, LLC | 3,493,235 9.990% | 3,493,235 (New Position) | Filing History |
| 2025-02-14 4:32 pm Sale | 2024-12-31 | 13G | BlackSky Technology Inc. BKSY | Nantahala Capital Management, LLC | 1,377,060 4.470% | -1,072,940 (-43.79%) | Filing History |
| 2025-02-14 4:32 pm Sale | 2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Nantahala Capital Management, LLC | 2,507,125 5.730% | -1,170,614 (-31.83%) | Filing History |